BUSINESS ACCOUNT
Access reports individually or via Subscription
Receive monthly invoices with payment via CSA or hard dollars
Analyst access
Free Trial Subscriptions
Team account with shared subscriptions
Advanced analytics to track research consumption and performance
4Q'25 vs. 4Q'24 Results Sales: € 1.31 Bn (-1.3% vs. -24.1% BS(e) and -18.8% consensus); EBITDA: € 32 M (-78.7% vs. +116.6% BS(e) and +80.2% consensus); EBIT: € -23 M (116 M in 4Q'24 vs. 10 M BS(e) and 17 M consensus); Net Profit: € -47 M (€ 63 M in 4Q’24 vs. -15 M BS(e) and 17 M consensus); 2025 vs. 2024 Results Sales: € 5.78 Bn (+6.8% vs. +8.4% BS(e) and +6.2% consensus); EBITDA: € 354 M (-29.2% vs. -23.6% BS(e) and -20.0% consensus); EBIT: € 153 M (-56.0% vs. -46.6% BS(e) and -44.5% consensus...
4Q'25 vs. 4Q'24 Results Sales: € 315.12 M (+3.1% vs. +0.1% BS(e) and +2.2% consensus); EBITDA: € 71.75 M (-9.1% vs. +0.7% BS(e) and -2.3% consensus). FY2025 vs. FY2024 Results Sales: € 1.252 Bn (+4.0% vs. +3.2% BS(e) and +3.8% consensus); EBITDA: € 289.99 M (+1.6% vs. +4.3% BS(e) and +3.5% consensus).
4Q'25 vs. 4Q'24 Results Sales: € 1.058 Bn (+1.9% vs. -1.4% BS(e) and +1.0% consensus); EBITDA: € 881.0 M (+2.1% vs. +0.1% BS(e) and +1.0% consensus); FY2025 vs. FY2024 Results Sales: € 3.995 Bn (+1.4% vs. +0.5% BS(e) and +1.1% consensus); EBITDA: € 3.317 Bn (+2.1% vs. +1.5% BS(e) and +1.8% consensus); Net Profit: € -361.0 M (€ -28.0 M in FY2024);
Rdos. 2025 vs 2024: Ventas: 4.660 M euros (+1,9% vs +2,4% BS(e) y +2,0% consenso); EBITDA: 1.358 M euros (+0,4% vs +2,4% BS(e) y +1,4% consenso); EBIT: 1.089 M euros (-11,1% vs -15,7% BS(e) y -13,2% consenso); BDI: 86,0 M euros (-23,9% vs -25,6% BS(e) y -23,0% consenso);